Active Pharmaceutical Ingredient (API) Market Size is Projected to Jump USD 260 Billion by 2026
The global Active Pharmaceutical Ingredient (API) Market size is anticipated to around USD 260 billion by 2026, this market is anticipated to grow with 6.5% CAGR during the forecast time period.
The report categorizes market in terms of various criteria, to identify the most lucrative segments. It reveals the growth drivers and restraints that are expected to chalk the market's trajectory in the coming years. It is compilation of various information of the market obtained via primary and secondary research methods. It also calculates the current active pharmaceutical ingredient market size, besides offering refined growth forecasts on the market. In addition to this the report includes competitive benchmarking, price trend analysis, and evaluation of the latest trends and dynamics, all compiled together in a logical chapter-wise format.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/146
Expansion of Biopharmaceutical Sector to Boost Growth
In the coming years, the market is expected to gain pace as a result of recent advancements in the biopharmaceutical sector. In addition to this, the rising geriatric population is expected to give impetus to the market. In the last couple of years the incidence of hospital acquired infection has surged considerably. With this, the incidence of cardiovascular, genetic, and neurological diseases has increased as well. According to the World Health Organization, cardiovascular diseases claim 17.9 million lives every year. They account for 31% of deaths worldwide, which is why the demand for advanced treatments has skyrocketed. Spurred by this, the active pharmaceutical ingredient market is expected to witness high demand in the coming years.
Synthetic Segment to Witness High Demand
In terms of synthesis, the market can be segmented into synthetic and biotech type. Of these, the synthetic segment is expected to witness considerably high demand. Growth witnessed in this segment is attributable to the easy availability of required raw materials and simplicity of the procedure. However, in the coming years, the biotech segment is likely to rise at a higher CAGR. The rising demand for biopharmaceutical and recent technological advancements are expected to boost growth in this segment.
Demand for Generic Drugs Expected to Rise in India and Brazil
In terms of manufacturer, the market can be segmented into merchant and captive API. Of these the captive API segment is forecast to emerge dominant. However, the merchant API segment is expected to record growth at a higher rate. In terms of type, the market can be categorized into innovative active pharmaceutical ingredient and generic pharmaceutical ingredient. The rising research and development initiatives are expected to boost growth of the innovative API segment. The generic drug segment will gain pace in response to the patent expiry of various blockbuster drugs. Also the availability of generic variants at a lower cost will bode well for the growth of the overall market. In India and Brazil and various other emerging nations the demand for generic drugs is expected to steadily rise.
On the basis of application, the global active pharmaceutical ingredient market can be segmented into oncology, CNS & Neurology, cardiology, orthopaedic, pulmonology, endrocrinology, nephrology, gastroenterology, ophthalmology, and others. Of these, the oncology segment is expected to rise at the highest pace. The rising prevalence of cancer and lifestyle changes will fuel demand in this segment. Furthermore, the rising investment in research and development will boost growth in the oncology segment.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/active-pharmaceutical-ingredients-api-market
Active Pharmaceutical Ingredient (API) Market (By Type of Synthesis: Biotech [Monoclonal antibodies, Recombinant proteins, Vaccines], Synthetic; By Type of Manufacturer: Captive APIs, Merchant APIs; By Type: Innovative APIs, Generic APIs; By Application: Cardiology [Generic, Innovative], Orthopedic [Generic, Innovative], Oncology [Generic, Innovative], Endocrinology [Generic, Innovative], Pulmonology [Generic, Innovative], Gastroenterology [Generic, Innovative], CNS & Neurology[Generic, Innovative], Nephrology [Generic, Innovative], Ophthalmology [Generic, Innovative], Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026
North America Emerges as Lucrative Market
Regionally, North America is expected to offer environment conducive to the growth of the global active pharmaceutical ingredient market. The region is witnessing a rising prevalence of cancer. This, coupled with increasing incidence of lifestyle-induced diseases will boost growth in the region. Furthermore, Asia Pacific is expected to emerge as the fastest growing market for active pharmaceutical ingredient.
Some of the leading companies operating in the global active pharmaceutical market are AbbVie Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd; Albemarle Corporation; Cipla, Inc.; Bristol-Myers Squibb Company; Mylan N.V.; Aurobindo Pharma; Sun Pharmaceutical Industries Ltd.; and Dr. Reddy's Laboratories Ltd. The market however is consolidated in nature. The report profiles some of the leading companies operating in the global market and gauges their strengths and weaknesses. Strategies adopted by these companies to gain competitive strength are analyzed. The effect of those strategies on the overall market is studied in detail as well.
Market Segmentation
Industry, by Type of Synthesis
- Biotech
- Monoclonal antibodies
- Recombinant proteins
- Vaccines
- Synthetic
Market, by Type of Manufacturer
- Captive APIs
- Merchant APIs
Market, by Type
- Innovative APIs
- Generic APIs
Market, by Application
- Cardiology
- Generic
- Innovative
- Orthopedic
- Generic
- Innovative
- Oncology
- Generic
- Innovative
- Endocrinology
- Generic
- Innovative
- Pulmonology
- Generic
- Innovative
- Gastroenterology
- Generic
- Innovative
- CNS & Neurology
- Generic
- Innovative
- Nephrology
- Generic
- Innovative
- Ophthalmology
- Generic
- Innovative
- Others
Market, by Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
The market research study on “Active Pharmaceutical Ingredient (API) Market (By Type of Synthesis: Biotech [Monoclonal antibodies, Recombinant proteins, Vaccines], Synthetic; By Type of Manufacturer: Captive APIs, Merchant APIs; By Type: Innovative APIs, Generic APIs; By Application: Cardiology [Generic, Innovative], Orthopedic [Generic, Innovative], Oncology [Generic, Innovative], Endocrinology [Generic, Innovative], Pulmonology [Generic, Innovative], Gastroenterology [Generic, Innovative], CNS & Neurology[Generic, Innovative], Nephrology [Generic, Innovative], Ophthalmology [Generic, Innovative], Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global Active Pharmaceutical Ingredient (API) market segments with market dynamics and their impact. The report provides insights on global Active Pharmaceutical Ingredient (API) market by type of synthesis, type of manufacturer, type, application, and major geographic regions. The report also covers basic technology development policies.
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/146
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Active Pharmaceutical Ingredient (API)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Active Pharmaceutical Ingredient (API) Market By Type of Synthesis
1.2.2.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Synthesis (2015-2026)
1.2.2.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Synthesis in 2017
1.2.2.3. Biotech
1.2.2.3.1. Monoclonal antibodies
1.2.2.3.2. Recombinant proteins
1.2.2.3.3. Vaccines
1.2.2.4. Synthetic
1.2.3. Active Pharmaceutical Ingredient (API) Market By Type of Manufacturer
1.2.3.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type of Manufacturer (2015-2026)
1.2.3.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type of Manufacturer in 2017
1.2.3.3. Captive APIs
1.2.3.4. Merchant APIs
1.2.4. Active Pharmaceutical Ingredient (API) Market By Type
1.2.4.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.4.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Type in 2017
1.2.4.3. Innovative APIs
1.2.4.4. Generic APIs
1.2.5. Active Pharmaceutical Ingredient (API) Market By Application
1.2.5.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.5.2. Global Active Pharmaceutical Ingredient (API) Market Revenue Share By Application in 2017
1.2.5.3. Cardiology
1.2.5.4. Orthopedic
1.2.5.5. Oncology
1.2.5.6. Endocrinology
1.2.5.7. Pulmonology
1.2.5.8. Gastroenterology
1.2.5.9. CNS & Neurology
1.2.5.10. Nephrology
1.2.5.11. Ophthalmology
1.2.5.12. Others
1.2.6. Active Pharmaceutical Ingredient (API) Market by Geography
1.2.6.1. Global Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2017
CHAPTER 4. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF SYNTHESIS
4.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Synthesis
4.2. Biotech
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Monoclonal antibodies
4.2.4. Recombinant proteins
4.2.5. Vaccines
4.3. Synthetic
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE OF MANUFACTURER
5.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type of Manufacturer
5.2. Captive APIs
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Merchant APIs
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY TYPE
6.1. Global Active Pharmaceutical Ingredient (API) Revenue By Type
6.2. Innovative APIs
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Generic APIs
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY APPLICATION
7.1. Global Active Pharmaceutical Ingredient (API) Revenue By Application
7.2. Cardiology
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.2.3. Generic
7.2.4. Innovative
7.3. Orthopedic
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3.3. Generic
7.3.4. Innovative
7.4. Oncology
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4.3. Generic
7.4.4. Innovative
7.5. Endocrinology
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5.3. Generic
7.5.4. Innovative
7.6. Pulmonology
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6.3. Generic
7.6.4. Innovative
7.7. Gastroenterology
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7.3. Generic
7.7.4. Innovative
7.8. Others
7.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
8.1. North America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Active Pharmaceutical Ingredient (API) Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
8.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
9.1. Europe Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
10.1. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
11.1. Latin America Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
12.1. Middle East Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 13. AFRICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET BY COUNTRY
13.1. Africa Active Pharmaceutical Ingredient (API) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Active Pharmaceutical Ingredient (API) Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.3.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.3.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.4.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.4.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Type of Synthesis, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Type of Manufacturer, 2015 - 2026 ($Million)
13.5.3. Market Revenue and Forecast By Type , 2015 - 2026 ($Million)
13.5.4. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 14. COMPANY PROFILE
14.1. AbbVie Inc.
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Merck & Co., Inc.
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Boehringer Ingelheim International GmbH
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Teva Pharmaceutical Industries Ltd; Cipla, Inc.
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Albemarle Corporation
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Bristol-Myers Squibb Company
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Sun Pharmaceutical Industries Ltd.
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Mylan N.V.
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Aurobindo Pharma
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Dr. Reddy’s Laboratories Ltd.
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/146
If you would like to place an order or have any questions, please feel free to contact at [email protected] | +1 407 915 4157 OR +1 408 900 9135
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Phone: +14079154157 | +14089009135
Website: https://www.acumenresearchandconsulting.com